Fiche publication
Date publication
mars 2026
Journal
Annals of oncology : official journal of the European Society for Medical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BOULAGNON-ROMBI Camille
Tous les auteurs :
Cheng Y, Azouzi N, Laurent-Bellue A, Guo Z, Chung T, Zeng Q, Ghodsifard A, Albrecht T, Roessler S, Boulagnon-Rombi C, Vij M, Rela M, Akpinar R, Augustin J, Bazille C, Xu S, Kong S, Lechapt-Zalcman E, Tournigand C, Kempf E, Brustia R, Pawlotsky JM, Braconi C, Caruso S, Ziol M, Goeppert B, Di Tommaso L, Park YN, Calderaro J
Lien Pubmed
Résumé
Intrahepatic cholangiocarcinoma (ICCA) is a rare but highly lethal adenocarcinoma arising within the hepatic parenchyma. Diagnosis presents a significant clinical challenge as the histological features of ICCA substantially overlap with those of metastatic liver cancers. This diagnostic ambiguity often necessitates extensive and costly exclusionary investigations, such as upper and lower gastrointestinal endoscopy, to rule out an occult primary site. Consequently, this process results in treatment delays and an increased financial burden on healthcare systems.
Mots clés
Deep learning, artificial intelligence, cholangiocarcinoma, confidence, pathology
Référence
Ann Oncol. 2026 03 4;:
